Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Aurobindo Eyes Opportunities After Offloading Natrol For $550m
US-Based Nutritionals Firm To Be Sold After Six Years
Oct 29 2020
•
By
Dean Rudge
Aurobindo may eye further M&A with the cash derived from the sale of Natrol. • Source: Shutterstock
More from Deals
More from Business